A Phase 1 Study To Evaluate The Safety, Pharmacokinetics And Pharmacodynamics Of Escalating Doses Of A Vaccine-based Immunotherapy Regimen (Vbir) For Prostate Cancer (Pf-06753512)

What is the purpose of this trial?

The study will evaluate the safety, pharmacokinetics and pharmacodynamics of increasing doses of a vaccine-based immunotherapy regimen for patients with prostate cancer.


Participation Guidelines

Ages: 18 years and older

Gender: Male only


Pfizer Inc., U.S. Pharmaceuticals Group

Dates: 04/03/2017 - 10/31/2018

Last Updated: 04/20/2017

Study HIC#: 1512016984